Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Accumulated Expenses (2018 - 2019)

Historic Accumulated Expenses for DiaMedica Therapeutics (DMAC) over the last 2 years, with Q3 2019 value amounting to $837000.0.

  • DiaMedica Therapeutics' Accumulated Expenses changed N/A to $837000.0 in Q3 2019 from the same period last year, while for Sep 2019 it was $837000.0, marking a year-over-year change of. This contributed to the annual value of $808000.0 for FY2018, which is N/A changed from last year.
  • Per DiaMedica Therapeutics' latest filing, its Accumulated Expenses stood at $837000.0 for Q3 2019.
  • In the past 5 years, DiaMedica Therapeutics' Accumulated Expenses ranged from a high of $837000.0 in Q3 2019 and a low of $630000.0 during Q2 2019